openPR Logo
Press release

Cancer Pain Market Huge Growth Opportunities | Industry Trends | Market Analysis & Global Forecast to 2027

01-27-2020 06:51 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Cancer Pain Market

Cancer Pain Market

According to the report, the global cancer pain market garnered $5.52 billion in 2018, and is estimated to reach $7.54 billion by 2025, registering a CAGR of 4.5% from 2018 to 2025.

Increase in incidence of cancer worldwide, surge in healthcare expenditure, and advancements in technology drive the growth in the market. However, adverse effects related to usage of drugs for cancer pain management restrain the market growth. On the other hand, surge in number of pipeline drugs create new opportunities in the industry.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5123

Opioids segment to continue its dominant position throughout the forecast period

Based on drug type, the opioids segment contributed the highest market share in 2018, accounting for nearly three-fifths of the total share, and is expected to continue its dominant position throughout the forecast period. Moreover, this segment is expected to grow at the highest CAGR of 5.0% from 2018 to 2025. This is attributed to rise in adoption of opioids for management of cancer pain and their nature of being the FDA-approved first line drugs for treating moderate or severe chronic cancer pain. The report also analyzes non-opioids and nerve blockers segments. The report also analyzes colorectal cancer, breast cancer, prostate cancer, blood cancer, and others.

Lung cancer segment to maintain its leadership status during the forecast period

Based on disease indication, the lung cancer segment held the major share in 2018, contributing for nearly one-fourth of the total market share, and is expected to maintain its leadership status during the forecast period. In addition, this segment would grow at the fastest CAGR of 6.1% from 2018 to 2025. This is a lucrative segment, owing to high prevalence of lung cancer and increase in the usage of cancer pain killers to get relief, upsurge in cigarette smoking population, and availability of advanced diagnostic techniques.

North America to maintain its highest share by 2025

Based on region, North America accounted for the major market share in 2018, accounting for more than two-fifths of the total market share. This region is expected to maintain its highest share during the forecast period. This is due to rapid increase in prevalence of different types of cancers, advancements in technologies, ease in availability of pain therapeutics, and availability of premiere chemotherapy treatments. On the other hand, Asia-Pacific would register the fastest growth rate with a CAGR of 5.4% from 2018 to 2025, owing to rise in prevalence of cancer in China, Japan, and India, increase in early screening of cancer, and surge in availability of pain therapeutics.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5123

Frontrunner of the industry

Leading market players analyzed in the research Aoxing Pharmaceutical Company, Inc., Daiichi Sankyo Co., Ltd., BioDelivery Sciences International, Inc., Hisamitsu Pharmaceutical Co., Inc., Grunenthal Pharma GmbH & Co. KG, Mundipharma International Limited, Insys Therapeutics, Inc., Pfizer Inc., Orexo AB, and Teva Pharmaceutical Industries Limited.

Related Reports:
Antiemetics Market
https://www.alliedmarketresearch.com/antiemetics-market

STDs Diagnosis Market
https://www.alliedmarketresearch.com/STDs-diagnosis-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Pain Market Huge Growth Opportunities | Industry Trends | Market Analysis & Global Forecast to 2027 here

News-ID: 1909951 • Views: 596

More Releases from Allied Market Research

Automotive Embedded Telematics Market 2020: Key Factors, Growth Opportunities an …
The Objective of the "Global Automotive Embedded Telematics Market" report is to depict the trends and upcoming for the Automotive Embedded Telematics Market industry over the forecast years. Automotive Embedded Telematics Market report data has been gathered from industry specialists/experts. Although the market size of the market is studied and predicted from 2020 to 2030 mulling over 2019 as the base year of the market study. Attentiveness for the market
Home Control & Security Systems Market 2020: New Advanced Technologies, Top Impa …
The Objective of the "Global Home Control & Security Systems Market" report is to depict the trends and upcoming for the Home Control & Security Systems Market industry over the forecast years. Home Control & Security Systems Market report data has been gathered from industry specialists/experts. Although the market size of the market is studied and predicted from 2020 to 2030 mulling over 2019 as the base year of the
Hospital-based EMR Market Statistics 2020: Demand, Strategic Analysis of Growth …
The Objective of the "Global Hospital-based EMR Market" report is to depict the trends and upcoming for the Hospital-based EMR Market industry over the forecast years. Hospital-based EMR Market report data has been gathered from industry specialists/experts. Although the market size of the market is studied and predicted from 2020 to 2030 mulling over 2019 as the base year of the market study. Attentiveness for the market has increased in
IPTV Access Infrastructure Market Outlook 2020: Demand, Opportunities and Advanc …
The Objective of the "Global IPTV Access Infrastructure Market" report is to depict the trends and upcoming for the IPTV Access Infrastructure Market industry over the forecast years. IPTV Access Infrastructure Market report data has been gathered from industry specialists/experts. Although the market size of the market is studied and predicted from 2020 to 2030 mulling over 2019 as the base year of the market study. Attentiveness for the market

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and